isabelle peene, MD,PhD

University Hospital Ghent
Ghent, Belgium

to be completed

Presentation(s):

• 0694: Treatment of Sjögren’s disease by blocking FcRn: clinical and translational data from RHO, a phase 2 randomized, placebo controlled, double-blind, proof-of-concept study with efgartigimod

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): argenx: Advisor or Review Panel Member (Ongoing)